Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,00%
1 108,28
+0,050
+0,00%
—1 108,231 109,651 115,881 105,94——
SIXC
Communications
SIXC
Communications
SIXC
+0,70%
609,87
+4,24
+0,70%
—605,63605,63610,34602,96——
SIXE
Energy
SIXE
Energy
SIXE
-0,25%
1 206,92
-3,03
-0,25%
—1 209,951 210,981 211,681 197,20——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,40%
1 751,13
-7,10
-0,40%
—1 758,231 759,031 760,641 739,69——
SIXM
Financials
SIXM
Financials
SIXM
-1,02%
628,49
-6,45
-1,02%
—634,94632,49632,49627,63——
SIXR
Staples
SIXR
Staples
SIXR
-0,35%
849,35
-3,02
-0,35%
—852,37850,81859,97849,13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,67%
217,39
-1,46
-0,67%
—218,85218,85218,85215,61——
SIXT
Technology
SIXT
Technology
SIXT
+1,00%
3 563,83
+35,34
+1,00%
—3 528,493 565,203 568,633 509,18——
SIXU
Utilities
SIXU
Utilities
SIXU
-1,06%
905,11
-9,71
-1,06%
—914,82910,36910,36897,78——
SIXV
Health care
SIXV
Health care
SIXV
+0,42%
1 478,40
+6,13
+0,42%
—1 472,271 470,891 481,751 466,47——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,69%
2 407,08
+16,47
+0,69%
—2 390,612 387,312 408,252 373,97——
ONC:NASDAQ
BeOne Medicines AG
315,28 US$
+0,07%
(+0,20) 1K
13-may, 13:19:30 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
ONC tikeri uchun statistika yaratilmoqda...
Ochish
310,72 US$
Yuqori
316,13 US$
Past
307,21 US$
Bozor kapitali
39,14 mlrd
Oʻrtacha hajm
220,63 ming
Hajmi
56,83 ming
52 haftalik eng yuqori
385,22 US$
52 haftalik eng past
218,31 US$
Beta
0,50
Muomaladagi aksiyalar
118,57 mln
Xodimlar soni
12 ming
Yangiliklar
Internetdagi manbalardan
Profil
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market. BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
BeOne Medicines AG haqida
CEOJohn Vincent Oyler | John Vincent Oyler
Xodimlar soni12 ming
Asos solingan28-okt, 2010
Bosh ofislar-
Sektor-
Veb-saytbeonemedicines.com
Oxirgi hisobot
6-may, 2026
Moliya davri
Ch.1 2026
Normallashtirilgan EPS / Taxminiy
1,96 US$ / 0,81 US$
+143,25%musbat
Daromad / Taxminan
1,51 mlrd / 1,44 mlrd
+5,35%musbat
Q1 2026 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – USD
iyn, 2025
sen, 2025
dek, 2025
mar, 2026
Daromad
1,32 mlrd
1,41 mlrd
1,50 mlrd
1,51 mlrd
Sotilgan mahsulotning tannarxi
164,61 mln
196,51 mln
142,42 mln
167,22 mln
Daromad narxi
164,61 mln
196,51 mln
142,42 mln
167,22 mln
Tadqiqot va ishlanmalarga xarajatlar
524,90 mln
523,66 mln
615,42 mln
541,22 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
537,91 mln
529,00 mln
555,29 mln
555,10 mln
Operatsion xarajatlar
1,06 mlrd
1,05 mlrd
1,17 mlrd
1,10 mlrd
Jami operatsion xarajatlar
1,23 mlrd
1,25 mlrd
1,31 mlrd
1,26 mlrd
Operatsion daromad
87,88 mln
163,11 mln
185,04 mln
249,90 mln
Boshqa nooperatsion daromad
13,19 mln
-4,76 mln
4,16 mln
14,54 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
99,55 mln
147,16 mln
149,24 mln
259,22 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
102,67 mln
160,80 mln
189,96 mln
259,22 mln
Daromad soligʻi boʻyicha xarajat
5,23 mln
22,32 mln
82,74 mln
31,86 mln
Amaldagi soliq stavkasi
5,25%
15,17%
55,44%
12,29%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
94,32 mln
124,84 mln
66,50 mln
227,36 mln
Sof foyda marjasi
7,17%
8,84%
4,44%
15,02%
Har bir aksiya foydasi
0,84
1,09
0,58
1,96
Foizlar va investitsiyalardan olingan daromadlar
11,49 mln
13,79 mln
32,37 mln
27,66 mln
Foizlarni toʻlash xarajatlari
-7,99 mln
-10,76 mln
-32,47 mln
-32,89 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
3,50 mln
3,03 mln
-103,00 ming
-5,22 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
117,75 mln
198,86 mln
219,47 mln
289,30 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish